home / stock / cor / cor articles

COR Articles, CoreSite Realty Corporation - From 03/29/24

Stock Information
Company Name: CoreSite Realty Corporation
Stock Symbol: COR
Market: NYSE
Website: amerisourcebergen.com
Menu
COR COR Quote COR Short COR News COR Articles COR Message Board
Get COR Alerts

News, Short Squeeze, Breakout and More Instantly...
$1000 Invested In Cencora 5 Years Ago Would Be Worth This Much Today | Benzinga

Cencora (NYSE:COR) has outperformed the market over the past 5 years by 13.84% on an annualized basis producing an average annual return of 26.68%....
Cencora Recent Insider Activity | Benzinga

Revealing a significant insider sell on March 20, Elizabeth S Campbell, Executive Vice President at Cencora (NYSE:COR), as per the latest SEC filin...

Here's How Much $100 Invested In Cencora 10 Years Ago Would Be Worth Today | Benzinga

Cencora (NYSE:COR) has outperformed the market over the past 10 years by 2.6% on an annualized basis producing an average annual return of 13.25%. ...

Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years | Benzinga

Cencora (NYSE:COR) has outperformed the market over the past 5 years by 11.43% on an annualized basis producing an average annual return of 24.09%....
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation | Benzinga

The Federal Trade Commission (FTC) is reportedly launching an investigation into recent shortages of chemotherapies, including carboplatin, cisplat...

Insider Decision: Walgreens Boots Alliance Inc Offloads $991.64M Worth Of Cencora Stock | Benzinga

Walgreens Boots Alliance Inc, 10% Owner at Cencora (NYSE:COR), executed a substantial insider sell on February 9, according to an SEC filing. What ...

$1000 Invested In This Stock 15 Years Ago Would Be Worth $12,000 Today | Benzinga

Cencora (NYSE:COR) has outperformed the market over the past 15 years by 5.93% on an annualized basis producing an average annual return of 18.14%....
Drug Wholesale Firm Cencora Starts 2024 With Strong Growth, Lifts Annual Forecast On Commercial COVID-19 Vaccine Distribution | Benzinga

Cencora Inc’s (NYSE:COR), formerly AmerisourceBergen Corporation, first quarter 2024 adjusted EPS reached $3.28, up from $2.71 Y/Y,...

Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference | Benzinga

In a recent revelation, CNBC’s Mad Money host Jim Cramer disclosed that the financial market values artificial intelligence (AI) technology m...

Here's How Much You Would Have Made Owning Cencora Stock In The Last 20 Years | Benzinga

Cencora (NYSE:COR) has outperformed the market over the past 20 years by 7.34% on an annualized basis producing an average annual return of 14.73%....
Previous 10 Next 10